Article
Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
Annals of the New York Academy of Sciences - 1 Dec 2001
Fabian C J, Kimler B F
Abstract excerpt
Although tamoxifen appears to markedly reduce breast cancer risk in women with a prior diagnosis of atypical hyperplasia or in situ carcinoma, it is not clear what other groups of women receive substantial benefit. Major breast chemoprevention priorities are to (1) develop new agents that (a) have fewer side effects, (b) are effective in ER--as well as tamoxifen-resistant precancerous tissue, and (c) are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.